Open-angle glaucoma

Researchers at Assiut University are studying whether combining cataract surgery with a procedure called goniotomy safely lowers eye pressure and reduces the need for glaucoma medications. The trial enrolls 70 adults with cataract plus either primary open-angle or primary angle-c…

This trial tests whether high-dose nicotinamide, a form of vitamin B3, can slow the loss of retinal nerve cells in adults with mild to moderate open-angle glaucoma. Participants already on standard glaucoma treatment will be randomly assigned to also take nicotinamide tablets or …

This study tests whether removing the ripcord from a glaucoma drainage device more than 3 months after placement lowers eye pressure. Adults with glaucoma who have had the ripcord in place for over 3 months will have it removed during a routine clinic visit. Researchers will meas…

This trial tests a new device called VividFlo, a small implant placed under the eye's surface to help drain fluid and lower pressure in people with glaucoma. The study involves 10 adults with glaucoma in one eye, who will receive the implant during surgery. Researchers will track…

This trial compares two surgical implants—the Baerveldt Glaucoma Implant and the Paul Glaucoma Implant—in people with glaucoma that is not well controlled by eye drops. Both devices are tiny tubes placed in the eye to drain fluid and lower pressure. The study will track which imp…

This trial investigates whether a 12-week home-based circuit training program can reduce intraocular pressure and improve retinal health in people with glaucoma. Participants are randomly assigned to either the exercise program plus standard care or standard care alone. The study…

This study tests an experimental drug called REGN22530 in people with primary open angle glaucoma or ocular hypertension. The drug is designed to block a protein in the eye that causes fluid buildup and high pressure. Researchers are checking for side effects, how the drug moves …

This study compares three different devices used to perform a glaucoma surgery called goniotomy at the same time as cataract surgery. The goal is to see which device best lowers eye pressure and reduces the need for glaucoma medications over six months. About 132 adults with open…

This early study tests a small ring placed in the eye that slowly releases the drug bimatoprost to lower eye pressure in people with glaucoma or ocular hypertension. The ring is implanted during a quick surgery and may work for up to 3 years. The trial includes 24 adults and comp…

This study tests whether insulin eye drops can protect the optic nerve in people with open-angle glaucoma. Researchers will give 90 participants either insulin drops or placebo daily for up to 12 months. The main goal is to check safety, but they will also measure vision changes …

This Phase 3 trial tests a new eye drop, DNN.31.19.026, against a standard treatment (Cosopt) for people with high eye pressure or open-angle glaucoma. About 336 adults will use the drops twice daily for 56 days. The main goal is to see if the new drop lowers eye pressure better …

This study tests a new laser treatment called DSLT for people with high eye pressure or open-angle glaucoma who have already had a similar laser (SLT). The DSLT laser does not touch the eye, which may make it faster and more comfortable. Researchers want to see how well it lowers…

This study tests whether placing a temporary stitch inside a tiny drainage device (Preserflo) can reduce the risk of dangerously low eye pressure after glaucoma surgery. The device is already used in France to lower eye pressure, but low pressure can still happen. About 192 adult…

This study tests whether a laser treatment called DSLT can lower eye pressure and reduce the number of eye drops needed in Asian patients with normal tension glaucoma. About 40 adults will receive the laser and be followed for 12 months. The goal is to see if the laser can help c…

This study looks at how Rocklatan eye drops change blood flow in the eyes of 30 people with early-stage glaucoma. Researchers will use special imaging to measure blood flow before and after using the drops for up to a year. The goal is to better understand the drug's effects on e…

This study explores whether a novel computer-based visual task can detect early glaucoma by measuring how well people perceive contrast-modulated motion. Glaucoma often goes unnoticed because it starts in peripheral vision, and current tests may miss early damage. The researchers…

This study looks at 60 adults with high eye pressure or early open-angle glaucoma to see if combining advanced eye scans and vision tests can detect damage sooner. Participants will have standard eye exams plus special imaging of the optic nerve. The goal is to improve how doctor…

This trial tests whether a structured reading rehabilitation module can improve reading speed and reduce errors in people with glaucoma, a condition that often impairs vision. Participants will practice the module for 20-30 minutes daily, at least 3 days a week, for 6 months. The…

This study tests whether a combination of gentle brain stimulation and visual exercises can improve vision and daily function in people with glaucoma who have lost some side vision. About 56 adults with open-angle glaucoma will receive both real and sham treatments in a crossover…

This study tests whether daily SMS or WhatsApp reminders can help people with primary open-angle glaucoma stick to their eye-drop schedule. About 84 adults will be split into two groups: one gets the reminders plus weekly educational messages for 3 months, the other gets standard…

This study will test whether a special type of lens implant (extended depth-of-focus, or EDOF) can give better vision and more satisfaction than standard monofocal lenses for people with both glaucoma and cataracts. About 74 adults with early-to-moderate open-angle glaucoma will …

This study tests whether Lumify, a low-dose brimonidine eye drop already approved for redness, can safely reduce eye redness and eyelid droop in 60 glaucoma patients who already use stronger brimonidine drops. Researchers will measure redness, eye pressure, and eyelid position af…

This study looks at whether a common type of glaucoma eye drop (prostaglandin analogues) can protect the eye's nerve cells directly, not just by lowering eye pressure. Researchers will review medical records from 1500 adults with glaucoma over 3 years, comparing those on prostagl…

This study looks at whether different types of exercise (like walking or strength moves) and timing (morning vs. evening) can safely lower blood pressure in people with glaucoma and high blood pressure. About 60 adults will try four exercise sessions, and their blood pressure and…